NCT03240211 2025-08-26Study of Pembrolizumab Combined With Decitabine and Pralatrexate in PTCL and CTCLUniversity of VirginiaPhase 1 Active not recruiting37 enrolled
NCT01114282 2016-07-06Phase I Bortezomib (VELCADE) in Combo With Pralatrexate in Relapsed/Refractory MMStanford UniversityPhase 1 Completed11 enrolled
NCT01532011 2016-07-04Erlotinib in Combination With Pralatrexate in Advanced MalignanciesM.D. Anderson Cancer CenterPhase 1 Completed72 enrolled